共 218 条
[1]
Virani SS(2021)Heart disease and stroke statistics—2021 update: a report from the American Heart Association Circulation. 143 e254-e743
[2]
Alonso A(2015)Prevalence of and trends in diabetes among adults in the United States, 1988–2012 JAMA 314 1021-9
[3]
Aparicio HJ(2014)Diabetes as risk factor for incident coronary heart disease in women compared with men: a systematic review and meta-analysis of 64 cohorts including 858,507 individuals and 28,203 coronary events Diabetologia 57 1542-51
[4]
Benjamin EJ(2014)Diabetes as a risk factor for stroke in women compared with men: a systematic review and meta-analysis of 64 cohorts, including 775 385 individuals and 12 539 strokes Lancet 383 1973-80
[5]
Bittencourt MS(2019)Diabetes as a risk factor for heart failure in women and men: a systematic review and meta-analysis of 47 cohorts including 12 million individuals Diabetologia. 62 1550-1560
[6]
Callaway CW(2011)Meta-analysis of cohort and case-control studies of type 2 diabetes mellitus and risk of atrial fibrillation Am J Cardiol 108 56-62
[7]
Menke A(2021)Association of SGLT2 inhibitors with cardiovascular and kidney outcomes in patients with type 2 diabetes: a meta-analysis JAMA Cardiol 6 148-158
[8]
Casagrande S(2019)Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials Lancet Diabetes Endocrinol. 7 776-785
[9]
Geiss L(2021)A prospective randomized study comparing effects of empagliflozin to sitagliptin on cardiac fat accumulation, cardiac function, and cardiac metabolism in patients with early-stage type 2 diabetes: the ASSET study Cardiovasc Diabetol l 20 32-38
[10]
Cowie CC(2021)Effect of tofogliflozin on arterial stiffness in patients with type 2 diabetes: prespecified sub-analysis of the prospective, randomized, open-label, parallel-group comparative UTOPIA trial Cardiovasc Diabetol 20 4-7